SQZ Biotechnologies Company (SQZ) Noticias

SQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio Updates

Phase 1 SQZ-AAC-HPV-101 Clinical Trial Resumed Following the Observation of a Confirmed Complete Response in the First Patient in the...

Quarterly Report (10-q)

00http://fasb.org/us-gaap/2022#ProductMember0Q1--12-310001604477http://fasb.org/us-gaap/2022#ProductMember0false0001604477srt:MaximumMembersqz:Fo...

Annual Report to Security Holders (ars)

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   SCHEDULE 14A...

Proxy Statement (definitive) (def 14a)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549  ...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549  ...

Current Report Filing (8-k)

false000160447700016044772023-04-062023-04-06       UNITED STATES SECURITIES AND EXCHANGE COMMISSION...

SQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial

A confirmed complete response was observed in the first patient in the lowest-dose cohort of the Phase 1 SQZ-AAC-HPV-101 clinical trial...

SQZ Biotechnologies Reports Full Year 2022 Financial Results and Recent Portfolio Updates

Strategically Focused Company Structure to Prioritize Clinical Development and Deliver Critical, Clinical-Stage Data SQZ® eAPC Phase 1/2 Trial...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN...

Amended Statement of Ownership (sc 13g/a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549      ...

Amended Statement of Ownership (sc 13g/a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...